These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 18977210)

  • 1. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach.
    Sinha A; Srivastava N; Singh S; Singh AK; Bhushan S; Shukla R; Singh MP
    Clin Chim Acta; 2009 Feb; 400(1-2):14-20. PubMed ID: 18977210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
    Yin GN; Lee HW; Cho JY; Suk K
    Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.
    Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ
    Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping.
    Piubelli C; Fiorini M; Zanusso G; Milli A; Fasoli E; Monaco S; Righetti PG
    Proteomics; 2006 Apr; 6 Suppl 1():S256-61. PubMed ID: 16511811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of protein depletion methods for the analysis of total-, phospho- and glycoproteins in lumbar cerebrospinal fluid.
    Ogata Y; Charlesworth MC; Muddiman DC
    J Proteome Res; 2005; 4(3):837-45. PubMed ID: 15952730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid.
    Yuan X; Desiderio DM
    Proteomics; 2005 Feb; 5(2):541-50. PubMed ID: 15627968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics analysis of human cerebrospinal fluid.
    Yuan X; Desiderio DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary analysis of cerebrospinal fluid proteome in patients with neurocysticercosis.
    Tian XJ; Li JY; Huang Y; Xue YP
    Chin Med J (Engl); 2009 May; 122(9):1003-8. PubMed ID: 19493432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
    Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
    Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of two-dimensional differential gel electrophoresis using cerebrospinal fluid from neurocysticercosis patients].
    Li JY; Tian XJ; Huang Y; Yang YJ; Ma QR; Xue YP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Jun; 26(3):174-8. PubMed ID: 19160961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.
    Salehi Z; Mashayekhi F
    J Clin Neurosci; 2009 Jan; 16(1):90-3. PubMed ID: 19017558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis.
    Koo BS; Lee DY; Ha HS; Kim JC; Kim CW
    J Proteome Res; 2005; 4(3):719-24. PubMed ID: 15952718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid proteome profile in multiple sclerosis.
    Lehmensiek V; Süssmuth SD; Tauscher G; Brettschneider J; Felk S; Gillardon F; Tumani H
    Mult Scler; 2007 Aug; 13(7):840-9. PubMed ID: 17881397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of serum proteomes to discover biomarkers for ossification of the posterior longitudinal ligament.
    Eun JP; Ma TZ; Lee WJ; Kim MG; Yoo MJ; Koh EJ; Choi HY; Kwak YG
    Spine (Phila Pa 1976); 2007 Apr; 32(7):728-34. PubMed ID: 17414905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation.
    Liu XD; Zeng BF; Xu JG; Zhu HB; Xia QC
    Proteomics; 2006 Feb; 6(3):1019-28. PubMed ID: 16372267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry.
    Paweletz CP; Wiener MC; Bondarenko AY; Yates NA; Song Q; Liaw A; Lee AY; Hunt BT; Henle ES; Meng F; Sleph HF; Holahan M; Sankaranarayanan S; Simon AJ; Settlage RE; Sachs JR; Shearman M; Sachs AB; Cook JJ; Hendrickson RC
    J Proteome Res; 2010 Mar; 9(3):1392-401. PubMed ID: 20095649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
    Jiang L; Lindpaintner K; Li HF; Gu NF; Langen H; He L; Fountoulakis M
    Amino Acids; 2003 Jul; 25(1):49-57. PubMed ID: 12836058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential proteomics analysis of mononuclear cells in cerebrospinal fluid of Parkinson's disease.
    Xing L; Wang D; Wang L; Lan W; Pan S
    Int J Clin Exp Pathol; 2015; 8(11):15462-6. PubMed ID: 26823915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia.
    Lehnert S; Jesse S; Rist W; Steinacker P; Soininen H; Herukka SK; Tumani H; Lenter M; Oeckl P; Ferger B; Hengerer B; Otto M
    Exp Neurol; 2012 Apr; 234(2):499-505. PubMed ID: 22327139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.